Literature DB >> 31321494

Two-step hysteroscopy for management of morbidly adherent retained products of conception.

Noam Smorgick1,2, Ira Rabinovitch3, Orna Levinsohn-Tavor3, Ron Maymon3, Zvi Vaknin3, Moty Pansky3.   

Abstract

PURPOSE: Retained products of conception (RPOC) may occur as the result of a morbidly adherent placenta. In these cases, the hysteroscopic removal of RPOC may be technically challenging, and may require more than one hysteroscopic procedure. We sought to compare the clinical, surgical, and postoperative characteristics of cases managed by either a one-step hysteroscopy procedure or a two-step hysteroscopy approach.
METHODS: A retrospective review of all RPOC cases managed by hysteroscopy from 1/2013 to 3/2018. We included cases of RPOC occurring following delivery and medical or surgical pregnancy terminations. The rates of postoperative intrauterine adhesions were assessed by office hysteroscopy.
RESULTS: A two-step procedure was required in 11 (3.9%) of the 358 women who underwent hysteroscopy for removal of RPOC during the study period. Comparison between the two-step and the one-step procedure groups revealed that the women in the two-step group were significantly older and the mean RPOC size was significantly larger (35.5 ± 4.1 years versus 30.7 ± 5.9 years, respectively, p = 0.01, and 38.6 ± 9.8 mm versus 22.3 ± 7.5 mm, p < 0.001, respectively). While the rates of intraoperative complications were similar between groups, readmission for postoperative fever was more common in the two-step group (18.2% versus 2.0%, respectively, p = 0.03). Postoperative intrauterine adhesions were diagnosed in 20.0% and 5.2%, respectively (p = 0.05).
CONCLUSIONS: The two-step hysteroscopic approach enabled the complete removal of larger RPOC masses without the use of uterine curettage. The women who underwent the two-step procedure, however, were at increased risk for postoperative fever and postoperative intrauterine adhesions.

Entities:  

Keywords:  Hysteroscopy; Placental remnants; Residual trophoblastic tissue; Retained products of conception

Year:  2019        PMID: 31321494     DOI: 10.1007/s00404-019-05246-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  1 in total

Review 1.  Hysteroscopy and Retained Products of Conception: An Update.

Authors:  Virginia Foreste; Alessandra Gallo; Alfonso Manzi; Carla Riccardi; Jose Carugno; Attilio Di Spiezio Sardo
Journal:  Gynecol Minim Invasive Ther       Date:  2021-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.